Quebec City, QC – The federal government and biotech company Advitech are together providing over $1 million to support a new collaborative research and development program on potential anti-inflammatory health benefits in cow’s milk.
The program, which will study growth hormones in cow’s milk that may have anti-inflammatory properties that can be used to treat chronic inflammatory diseases, will be based at Universit Laval.
The federal government will contribute $610,000 over three years through NSERC’s collaborative research and development program, and Advitech will contribute $305,000. It will also provide substantial resources in the form of goods and services to support the program’s research activities.
“We are devising new strategies to extract growth factors in cow’s milk and assess their effects in animals. Our ultimate objective is to develop natural health products that target chronic inflammatory diseases such as Crohn’s disease, ulcerative colitis and arthritis,” says Dr Sylvie Gauthier, the project’s director.